Q4 2018 Holdings
Filed 2019-02-14 | 100 holdings | $52.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $10.2M | 1,232,089 | 19.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $8.4M | 87,081 | 16.0% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $7.5M | 447,970 | 14.3% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $6.7M | 202,994 | 12.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $4.1M | 273,151 | 7.9% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $3.7M | 58,273 | 7.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $3.5M | 271,053 | 6.7% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $3.1M | 67,500 | 6.0% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $3.1M | 113,437 | 5.9% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $1.2M | 321,430 | 2.3% |
| Spdr Series Trust(XBI)Put | PUT | 78464A870 | $193.7K | 2,700,000 | 0.4% |
| Mylan N V | SHS EURO | N59465109 | $46.0K | 1,677,241 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $36.1K | 472,000 | 0.1% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $32.7K | 630,000 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $29.8K | 465,000 | 0.1% |
| Caesarstone LTD(CSTE) | ORD SHS | M20598104 | $23.8K | 469,160 | 0.0% |
| Verint SYS Inc(VTY) | COM | 92343X100 | $23.6K | 149,100 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $23.5K | 2,447,994 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $21.9K | 350,000 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $19.6K | 515,000 | 0.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $17.8K | 46,998 | 0.0% |
| Palo Alto Networks Inc(PANW) | COM | 697435105 | $17.5K | 24,885 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $16.4K | 168,100 | 0.0% |
| Ituran Location and Control(ITRN) | SHS | M6158M104 | $14.6K | 122,177 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $13.8K | 138,796 | 0.0% |
| Allot Communications LTD(ALLT) | SHS | M0854Q105 | $13.5K | 595,764 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $12.7K | 116,517 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $12.4K | 221,269 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $11.9K | 345,500 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $11.8K | 310,000 | 0.0% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADR | 881624209 | $10.9K | 704,500 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $10.1K | 706,539 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $9.9K | 103,500 | 0.0% |
| Mellanox Technologies LTD | SHS | M51363113 | $9.8K | 28,351 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $8.2K | 8,200,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $7.5K | 77,000 | 0.0% |
| Retrophin Inc | COM | 761299106 | $7.4K | 325,678 | 0.0% |
| Osmotica Pharmaceuticals PLC | SHS | G6S41R101 | $7.1K | 922,200 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $6.7K | 232,849 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $6.0K | 147,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $5.8K | 370,000 | 0.0% |
| Forescout Technologies Inc(FSCTEUR) | COM | 34553D101 | $5.7K | 59,169 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $5.7K | 745,727 | 0.0% |
| Gilat Satellite Networks LTD(GILT) | SHS NEW | M51474118 | $5.7K | 166,663 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $5.6K | 2,032,643 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $5.4K | 340,000 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $5.3K | 782,018 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $4.9K | 133,015 | 0.0% |
| Mohawk Inds Inc(MHK) | COM | 608190104 | $4.7K | 10,661 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $4.6K | 749,502 | 0.0% |